← All organizations

Ocugen

For profitWebsite ↗

Also known as: Ocugen | Ocugen, Inc. | Ocugen., Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 25, 2023

Timeline

2010s

Jun 1, 2013
Ocugen— Founded
Sep 30, 2019
Histogenics Corporation— Acquired

Drugs by trial phase (7 distinct, 13 trials)

Phase 3 (2 own, 1 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ocu200

Indications

Studied for

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (17)

NCT06574997OfficialN/A—
NCT06574997Lead sponsorN/A—
NCT05541289Lead sponsorN/A—
NCT05956626OfficialPhase 1/Phase 2Aug 25, 2023
NCT05956626Lead sponsorPhase 1/Phase 2Aug 25, 2023
NCT06018558Lead sponsorPhase 1/Phase 2Aug 23, 2023
NCT06018558Study directorPhase 1/Phase 2Aug 23, 2023
NCT05802329Study directorPhase 1Apr 30, 2023
NCT05802329Lead sponsorPhase 1Apr 30, 2023
NCT05258669Lead sponsorPhase 2/Phase 3Feb 20, 2022
NCT05258669Study directorPhase 2/Phase 3Feb 20, 2022
NCT05203939Lead sponsorPhase 1/Phase 2Jan 24, 2022
NCT03785340Lead sponsorPhase 3Dec 3, 2018
NCT03591874Lead sponsorPhase 3Sep 18, 2018
NCT03591874Study directorPhase 3Sep 18, 2018

Details

Founded: Malvern, PA, US Jun 1, 2013
Last known activity: Aug 25, 2023